title: Authors' reply to Srinivas: "pharmacokinetics and tolerability of the novel oral prostacyclin IP receptor agonist selexipag".
authors: Department of Clinical Pharmacology, Actelion Pharmaceuticals Ltd, Gewerbestrasse 16, 4123, Allschwil, Switzerland. priska.kaufmann@actelion.com.
authors: Priska
authors: P
authors: Kaufmann
authors: Department of Clinical Pharmacology, Actelion Pharmaceuticals Ltd, Gewerbestrasse 16, 4123, Allschwil, Switzerland.
authors: Jasper
authors: J
authors: Dingemanse
mesh_terms: D000081:Acetamides / Q000008:administration & dosage*; D000085:Acetates / Q000493:pharmacokinetics*; D018565:Food-Drug Interactions; D006801:Humans; D008297:Male; D011719:Pyrazines / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D044006:Receptors, Epoprostenol / Q000819:agonists*
chemical_list: D000081:Acetamides; D000085:Acetates; D011719:Pyrazines; D044006:Receptors, Epoprostenol